IRIS
FALOPPI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.930
EU - Europa 901
AS - Asia 355
AF - Africa 56
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.254
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.930
IT - Italia 202
UA - Ucraina 193
SE - Svezia 122
SG - Singapore 115
IE - Irlanda 108
TR - Turchia 100
DE - Germania 88
CN - Cina 86
DK - Danimarca 76
FI - Finlandia 61
KR - Corea 41
CI - Costa d'Avorio 33
GB - Regno Unito 26
MA - Marocco 20
FR - Francia 14
IN - India 9
BR - Brasile 7
NL - Olanda 4
BD - Bangladesh 3
DZ - Algeria 3
EU - Europa 3
BE - Belgio 2
RU - Federazione Russa 2
AR - Argentina 1
BG - Bulgaria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
KG - Kirghizistan 1
RS - Serbia 1
Totale 3.254
Salva come PNG Salva come JPEG
Città #
Chandler 253
Fairfield 219
Jacksonville 210
Ashburn 128
Wilmington 124
Dublin 108
Boardman 100
Seattle 89
Woodbridge 89
Centro 73
Houston 69
New York 69
Cambridge 66
Ann Arbor 61
Des Moines 53
Singapore 51
Lawrence 44
Princeton 44
San Mateo 44
Turin 35
Abidjan 33
Helsinki 22
Beijing 16
San Diego 16
London 9
Pune 9
Wuxi 8
Izmir 7
Los Angeles 6
Washington 6
Norwalk 5
Shanghai 5
Kilburn 4
Wuhan 4
Ancona 3
Belo Horizonte 3
Dallas 3
Fayetteville 3
Guangzhou 3
Milan 3
New Bedfont 3
Portland 3
Prescot 3
Amsterdam 2
Brussels 2
Chicago 2
Chiswick 2
Como 2
Dalian 2
Florence 2
Isola della Scala 2
Jinhua 2
Modena 2
Montesilvano 2
Roseto degli Abruzzi 2
San Francisco 2
Venice 2
Yiwu 2
Acton 1
Arcoverde 1
Ascoli Piceno 1
Belgrade 1
Betim 1
Bishkek 1
Bogotá 1
Campinas 1
Changsha 1
Chaozhou 1
Charata 1
Chizhou 1
Clifton 1
Cupra Marittima 1
Dhaka 1
Dongyang 1
Falkenstein 1
Foshan 1
Frankfurt (Oder) 1
Hangzhou 1
Hanover 1
Heze 1
Hounslow 1
Hwang Chow 1
Islington 1
Kolomna 1
Mafra 1
Matelica 1
Murmansk 1
Nanjing 1
Nantong 1
Olomouc 1
Pesaro 1
Porto 1
Qingdao 1
San Giuliano 1
Santa Clara 1
Seoul 1
Sofia 1
Stamford 1
Suzhou 1
Tiantai Chengguanzhen 1
Totale 2.178
Salva come PNG Salva come JPEG
Nome #
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 132
Immunotherapy in genitourinary cancers: Where are we going? 122
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 120
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 120
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 106
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 96
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 88
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 87
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 86
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 84
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 83
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 83
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 82
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 81
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 81
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 80
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 78
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 76
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 75
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 74
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 73
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 73
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 71
Panitumumab for the treatment of metastatic colorectal cancer: A review 71
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 71
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 71
Trattamento del carcinoma del pancreas. Attualità e prospettive 69
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 69
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 68
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 67
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 67
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 65
Gastric cancer: Therapeutic choices in advanced disease 65
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 65
Selecting the best treatment for an individual patient. 59
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 58
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 56
Tracking the 2015 gastrointestinal cancers symposium: Bridging cancer biology to clinical gastrointestinal oncology 56
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 55
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 54
Palliative treatment 53
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 53
Cetuximab: still an option in the treatment of pancreatic cancer? Expert Opin Biol Ther. 2013 May;13(5):791-801 52
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 48
Totale 3.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020164 0 0 0 0 0 0 40 4 41 2 16 61
2020/2021784 47 78 79 4 135 67 73 52 57 92 67 33
2021/2022357 28 82 7 6 2 23 15 24 20 54 26 70
2022/2023745 51 105 58 55 47 119 1 44 168 3 78 16
2023/2024388 59 4 39 50 60 104 6 4 1 6 7 48
2024/2025285 112 71 12 11 49 29 1 0 0 0 0 0
Totale 3.343